• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Impact of Disopyramide on Exercise Capacity Among Patients with Obstructive Hypertrophic Cardiomyopathy: Beyond LVOT Gradient.

作者信息

Halasz Geza, Dei Lorenzo Lupo, Moroni Francesco, Ayers Michael P, Ciacci Paolo, Giacalone Guido, Mistrulli Raffaella, Redivo Marco, Orellana Santiago, Gabrielli Domenico, Piepoli Massimo, Re Federica

机构信息

Division of Cardiology, Cardio-Thoracic and Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, ITALY.

University of L'Aquila, Department of Clinical Medicine, Public Health, Life and Environmental Science, L'aquila, Italy.

出版信息

Eur J Prev Cardiol. 2024 Jun 8. doi: 10.1093/eurjpc/zwae198.

DOI:10.1093/eurjpc/zwae198
PMID:38850169
Abstract
摘要

相似文献

1
The Impact of Disopyramide on Exercise Capacity Among Patients with Obstructive Hypertrophic Cardiomyopathy: Beyond LVOT Gradient.丙吡胺对梗阻性肥厚型心肌病患者运动能力的影响：超越左心室流出道梯度
Eur J Prev Cardiol. 2024 Jun 8. doi: 10.1093/eurjpc/zwae198.
2
Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.重新审视丙吡胺治疗有症状的梗阻性肥厚型心肌病：至少治疗5年患者的疗效和安全性
J Am Heart Assoc. 2025 Jan 21;14(2):e037639. doi: 10.1161/JAHA.124.037639. Epub 2025 Jan 16.
3
Efficacy of pharmacological therapies in reducing outflow tract obstruction in patients with obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis.药物治疗对梗阻性肥厚型心肌病患者减轻流出道梗阻的疗效：一项系统评价和荟萃分析
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):469-482. doi: 10.1093/ehjcvp/pvaf036.
4
Concomitant Aficamten and Disopyramide in Symptomatic Obstructive Hypertrophic Cardiomyopathy.阿非卡坦与丙吡胺联用治疗有症状的梗阻性肥厚型心肌病
JACC Heart Fail. 2025 Apr 2. doi: 10.1016/j.jchf.2025.03.008.
5
Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.丙吡胺对肥厚型梗阻性心肌病左心室舒张功能的有益作用。
J Am Coll Cardiol. 1995 Sep;26(3):768-75. doi: 10.1016/0735-1097(95)00229-W.
6
Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial.无左心室流出道梗阻的肥厚型心肌病患者的运动训练：一项随机临床试验。
Circulation. 2025 Jan 14;151(2):132-144. doi: 10.1161/CIRCULATIONAHA.124.070064. Epub 2024 Nov 8.
7
Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy.对于既往接受过晚期治疗仍有症状的梗阻性肥厚型心肌病患者使用mavacamten治疗。
J Am Heart Assoc. 2025 Aug 5;14(15):e041565. doi: 10.1161/JAHA.125.041565. Epub 2025 Jul 17.
8
Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy.酒精间隔消融术对梗阻性肥厚型心肌病患者运动血流动力学、症状及生活质量的影响
J Am Heart Assoc. 2025 Aug 19;14(16):e041328. doi: 10.1161/JAHA.125.041328. Epub 2025 Aug 18.
9
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.肥厚型梗阻性心肌病的治疗药物：Aficamten
N Engl J Med. 2024 May 30;390(20):1849-1861. doi: 10.1056/NEJMoa2401424. Epub 2024 May 13.
10
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy.肥厚型心肌病左心室流出道梗阻的影像学表现。
Curr Opin Cardiol. 2023 Sep 1;38(5):405-414. doi: 10.1097/HCO.0000000000001058. Epub 2023 Apr 6.

引用本文的文献

1
Safety and Efficacy of Mavacamten and Aficamten in Patients With Hypertrophic Cardiomyopathy.马伐卡坦和阿非卡坦在肥厚型心肌病患者中的安全性和有效性
J Am Heart Assoc. 2025 Mar 18;14(6):e038758. doi: 10.1161/JAHA.124.038758. Epub 2025 Mar 7.
2
Disopyramide Revisited for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Efficacy and Safety in Patients Treated for at Least 5 Years.重新审视丙吡胺治疗有症状的梗阻性肥厚型心肌病：至少治疗5年患者的疗效和安全性
J Am Heart Assoc. 2025 Jan 21;14(2):e037639. doi: 10.1161/JAHA.124.037639. Epub 2025 Jan 16.
3
Advancements in the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Comprehensive Review.
肥厚型心肌病的诊断与治疗进展：综述
J Cardiovasc Dev Dis. 2024 Sep 18;11(9):290. doi: 10.3390/jcdd11090290.
4
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting.丙吡胺治疗梗阻性肥厚型心肌病患者的长期随访研究：现实临床环境中症状控制显著趋势的证据
Front Cardiovasc Med. 2024 Aug 14;11:1416600. doi: 10.3389/fcvm.2024.1416600. eCollection 2024.